Chronic Urticaria Or Hives – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Chronic Urticaria Or Hives – Drugs In Development, 2024 report and make more profitable business decisions.
Chronic urticaria, also known as hives, are outbreaks of swollen, pale red bumps, patches, or welts on the skin that appear suddenly either as a result of allergies, or for other reasons. The main symptom is itchy rashes. Chronic urticaria occurs when histamine and other chemicals are released from under the skin’s surface, causing the tissues to swell. Predisposing factors include stress, caffeine, warm temperatures, alcohol, and insect bites and stings. Treatment includes antihistamines and corticosteroids.
The Chronic Urticaria Or Hives drugs in development market research report provide comprehensive information on the therapeutics under development for Chronic Urticaria Or Hives, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Chronic Urticaria Or Hives and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Chronic Urticaria Or Hives | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 61 molecules, with 60 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Chronic Urticaria Or Hives therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Chronic Urticaria Or Hives pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Chronic Urticaria Or Hives treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Acelyrin IncAjou University Hospital
Allakos Inc
Amgen Inc
ARS Pharmaceuticals Inc
BCN Peptides SA
BiosanaPharma BV
Bioviz Technologies Pvt Ltd
Blueprint Medicines Corp
Carna Biosciences Inc
Celldex Therapeutics Inc
Cellix Bio Pvt Ltd
Celltrion Inc
Changchun Lanjiang Pharmaceutical Technology Co Ltd
CoSci Med-Tech Co Ltd
CSPC Baike Biopharmaceutical Co Ltd
Curateq Biologics Pvt Ltd
DongKoo Bio & Pharma Co Ltd
Escient Pharmaceuticals Inc
Evommune Inc
Faes Farma SA
Genentech USA Inc
Genrix (Shanghai) Biopharmaceutical Co Ltd
GENUONE Sciences Inc
Glenmark Pharmaceuticals Ltd
GSK plc
Hangzhou Highlightll Pharmaceutical Co Ltd
Incyte Corp
Inmagene Biopharmaceuticals Ltd
Intas Pharmaceuticals Ltd
Invea Therapeutics Inc
Jasper Therapeutics Inc
JiangSu Qyuns Therapeutics Co Ltd
JW Pharmaceutical Corp
Kashiv BioSciences LLC
KeifeRx LLC
Leo Pharma AS
Luye Pharma Group Ltd
Mirae Cell Bio Co Ltd
Novartis AG
OrchestratePharma GmbH
PharmAbcine Inc
Principia Biopharma Inc
RAPT Therapeutics Inc
Regeneron Pharmaceuticals Inc
Shandong New Era Pharmaceutical Co Ltd
Shanghai Pharmaceuticals Holding Co Ltd
Sichuan Yuanda Shuyang Pharmaceutical Co Ltd
Siolta Therapeutics Inc
STERO Biotechs Ltd
Synermore Biologics Co Ltd
Taiho Pharmaceutical Co Ltd
Teva Pharmaceutical Industries Ltd
Third Harmonic Bio Inc
Tianchen Biopharmaceutical (Suzhou) Co Ltd
United Biomedical Inc
United BioPharma Inc
Vitalli Bio
Yuhan Corp
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Chronic Urticaria Or Hives reports